Citi raised the firm’s price target on Corteva (CTVA) to $74 from $69 and keeps a Buy rating on the shares. The firm reduced Q4 earnings estimates and increased 2025 numbers for the agricultural chemicals to reflect reflect larger currency headwinds into 2025 from a strengthening U.S. dollar, offset by marginally better organic sales on a recovery year for crop chemicals and seeds.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.